|
|
Volumn 5, Issue 7, 1996, Pages 829-841
|
|
Thalidomide in autoimmune conditions
|
|
Author keywords
angiogenesis; autoimmune; graft versus host disease; human immunodeficiency virus; thalidomide; tumour necrosis factor
|
|
Indexed keywords
THALIDOMIDE;
TUMOR NECROSIS FACTOR;
ACTINIC KERATOSIS;
ANGIOGENESIS;
ANTIINFLAMMATORY ACTIVITY;
BEHCET DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISCOID LUPUS ERYTHEMATOSUS;
DRUG MECHANISM;
ERYTHEMA MULTIFORME;
GRAFT VERSUS HOST REACTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEPROMATOUS LEPROSY;
MAJOR CLINICAL STUDY;
NONHUMAN;
PERIPHERAL NEUROPATHY;
PHOCOMELIA;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
SEDATION;
TERATOGENICITY;
ULCERATIVE COLITIS;
VASCULITIS;
WEBER CHRISTIAN PANNICULITIS;
WEIGHT GAIN;
|
|
EID: 0029899677
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.7.829 Document Type: Review |
|
Times cited : (14)
|
|
References (0)
|
